Literature DB >> 11484692

Autoimmune diseases.

A Davidson1, B Diamond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11484692     DOI: 10.1056/NEJM200108023450506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  240 in total

Review 1.  Challenges to achieving clinical transplantation tolerance.

Authors:  A D Salama; G Remuzzi; W E Harmon; M H Sayegh
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 2.  Autoimmune diseases: are markers ready for prediction?

Authors: 
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity.

Authors:  M P Madaio
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

Review 4.  The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases.

Authors:  Alan Tyndall; Alois Gratwohl
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10.

Authors:  Jay S Fine; Alberto Rojas-Triana; James V Jackson; Laura W Engstrom; Gregory S Deno; Daniel J Lundell; Loretta A Bober
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

6.  Identification of beta-subunit of bacterial RNA-polymerase--a non-species-specific bacterial protein--as target of antibodies in primary biliary cirrhosis.

Authors:  Kai-Wolfgang Roesler; Wolfgang Schmider; Manfred Kist; Stephen Batsford; Emile Schiltz; Mathias Oelke; Anja Tuczek; Therese Dettenborn; Dirk Behringer; Wolfgang Kreisel
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

7.  Differential roles of estrogen receptors α and β in control of B-cell maturation and selection.

Authors:  Latia Hill; Venkatesh Jeganathan; Prameladevi Chinnasamy; Christine Grimaldi; Betty Diamond
Journal:  Mol Med       Date:  2010-11-22       Impact factor: 6.354

8.  Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis.

Authors:  K Bendtzen; P R Hansen; K Rieneck
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

9.  C1q limits dendritic cell differentiation and activation by engaging LAIR-1.

Authors:  Myoungsun Son; Frances Santiago-Schwarz; Yousef Al-Abed; Betty Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-23       Impact factor: 11.205

10.  Extracellular Vesicles: Evolving Contributors in Autoimmunity.

Authors:  Stergios Katsiougiannis
Journal:  For Immunopathol Dis Therap       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.